MARATTO

article · Nigerian Journal of Family Practice

PREDICTORS OF POST-COVID SYNDROME AMONG ADULT PATIENTS WITH COVID -19 INFECTION IN IBADAN, NIGERIA

Abstract

Background: While most individuals recover from acute Coronavirus disease (COVID-19), a subset experiences persistent symptoms, referred to as post-COVID-19 Syndrome (PCS). Understanding the clinical spectrum and determinants of PCS is essential to provide evidence-based long-term care for COVID-19 survivors. This study aimed to describe the clinical spectrum and predictors of PCS among hospitalized and non-hospitalized COVID-19 patients in Ibadan, Nigeria.Methods: A retrospective cross-sectional study involved 536 adult individuals who tested positive for SARS-CoV-2 via polymerase chain reaction (PCR) in Ibadan, Nigeria. Data, including demographics, symptoms, comorbidities, and quality of life, were collected using a semistructured questionnaire and analyzed with descriptive statistics. Pearson's Chi-square and logistic regression were used to assess associations and predictors of PCS.Results: Among the 536 participants, 98 (18.3%) had PCS. Of these, 67 (68.4%) reported mild symptoms, while 31 (31.6%) experienced severe symptoms. Common symptoms included fatigue/malaise (36.7%), headache (19.4%), cough (17.3%), and sore throat (13.3%). Comorbidities, initial COVID-19 severity, vaccination status pre-infection, treatment location, oxygen supplementation, and ICU care were associated with PCS. Logistic regression revealed that having received a pre-COVID-19 vaccination decreased the odds of PCS by 62.4% (aOR=0.376; 95% CI [0.205, 0.692]). Individuals that experienced PCS had lower quality of life scores (Mean EQ VAS score: 85.8) compared to those without PCS (89.7), with impacts across mobility, self-care, daily activities, pain/discomfort, and anxiety/depression domains in EQ-5D analysis.Conclusion: PCS affects a significant proportion of COVID-19 survivors in Ibadan, Nigeria. Pre-COVID-19 vaccination was associated with a reduced risk of PCS. Understanding the clinical and demographic factors predicting PCS can aid in providing long-term care and support for affected individuals.

Research topics

  • Long-Term Effects of COVID-19
  • Pharmacological Receptor Mechanisms and Effects
  • COVID-19 Clinical Research Studies

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.64052/v26v9k06

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.